PreveCeutical Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, net loss was CAD 0.611767 million compared to CAD 1.02 million a year ago. Basic loss per share from continuing operations was CAD 0.001.